FASN and colorectal carcinoma: At the molecular level, inhibition of CRC cell viability seems to be related to the inhibition of main drivers of the de novo lipogenesis, such as the sterol regulatory element binding transcription factor (SREBF1) and downstream molecular targets such as fatty acid synthase (FASN) and stearoyl coenzyme desaturase 1 (SCD1).